We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Bioreplaceable Suture Anchors aid Shoulder Stabilization

By HospiMedica staff writers
Posted on 17 Sep 2007
New suture anchors made from a biocomposite material have been proven in pre-clinical use to resorb and be replaced with bone within 24 months.

The Lupine BR and the Bioknotless BR bioreplaceable suture anchors, made from a proprietary material called biocryl rapide (BR), offer both traditional and knotless suture anchor options for surgical attachment of soft tissue to bone during arthroscopic shoulder instability repair, while maintaining design characteristics found in previous implants made of polylactic acid (PLA).

BR is a biocomposite material combining tricalcium phosphate (TCP) and polylactic/polyglycolic acid (PLGA). More...
A proprietary manufacturing process known as micro-particle dispersion (MPD) technology is used to make the BR material a homogeneous blend of PLGA and TCP particles. Dispersion of the composite particles is critical to the material strength properties. The material has shown marked absorption and a proliferation of bone cells after 18 months, with near total absorption in about 24 months. BR was developed by DePuy Mitek (Raynham, MA, USA), a Johnson and Johnson (New Brunswick, NJ, USA) company.

"Using Biocryl Rapide material in suture anchors is a natural progression in arthroscopic implant design,” said Mark H. Getelman, M.D., co-director of the sports medicine fellowship at Southern California Orthopedic Institute (SCOI; Van Nuys, CA, USA). "Since it combines an improved absorption profile with osteoconductive properties while maintaining all the strength characteristics seen with the widely used PLA implants, it may prove to be very beneficial clinically.”


Related Links:
DePuy Mitek
Johnson and Johnson

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.